Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The role of p62 in CRC was investigated in in vitro and in vivo functional studies.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor

Study design awaiting verification · Cell Proliferation · 2019

Original publication title

p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor

Jing Zhang; Suzhen Yang; Bing Xu; Ting Wang; Ying Zheng; Fei Liu; Fenggang Ren; Jiong Jiang; Haitao Shi; Baicang Zou; Xiaolan Lu; Shemin Lu; Lei Dong

© 2019 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our study suggested that p62 functions as an oncogene in CRC through inhibiting apoptosis and promoting cell proliferation by interacting with the VDR.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

The role of p62 in cancer is controversial. Evidence has shown that p62 is upregulated in different cancers and promotes tumour growth, such as in liver cancer and lung cancer. However, a recent study showed that the downregulation of p62 in hepatic stellate cells (HSCs) promotes hepatocellular carcinoma (HCC) development. How p62 is regulated in colorectal cancer (CRC) remains largely unknown. In this study, we aimed to investigate the roles and molecular mechanisms of p62 in CRC.

Source: Objectives

Abstract: What methods does the paper describe?

The expression levels of p62 in CRC tissues and adjacent non‐tumour tissues were determined by immunohistochemistry (IHC). Stable p62‐overexpression HCT116 cells and p62‐knockdown SW480 cells were established with lentiviral vectors. The role of p62 in CRC was investigated in in vitro and in vivo functional studies. The relationship between p62 and the vitamin D receptor (VDR) was investigated by coimmunoprecipitation (Co‐IP) assays.

Source: Materials and Methods

Abstract: Results

p62 was significantly upregulated in CRC, and a high p62 level was an independent risk factor for a poor prognosis in CRC patients. p62 promoted CRC migration and invasion by inhibiting apoptosis and promoting cell proliferation in vitro, and p62 aggravated tumour growth and metastasis in vivo. Co‐IP assays indicated that p62 interacts with the VDR and may target the NRF2‐NQO1 axis.

Source: Results

Abstract: Conclusions

Our study suggested that p62 functions as an oncogene in CRC through inhibiting apoptosis and promoting cell proliferation by interacting with the VDR.

Source: Conclusions
Authors’ abstract

Abstract

Objectives

The role of p62 in cancer is controversial. Evidence has shown that p62 is upregulated in different cancers and promotes tumour growth, such as in liver cancer and lung cancer. However, a recent study showed that the downregulation of p62 in hepatic stellate cells (HSCs) promotes hepatocellular carcinoma (HCC) development. How p62 is regulated in colorectal cancer (CRC) remains largely unknown. In this study, we aimed to investigate the roles and molecular mechanisms of p62 in CRC.

Materials and Methods

The expression levels of p62 in CRC tissues and adjacent non‐tumour tissues were determined by immunohistochemistry (IHC). Stable p62‐overexpression HCT116 cells and p62‐knockdown SW480 cells were established with lentiviral vectors. The role of p62 in CRC was investigated in in vitro and in vivo functional studies. The relationship between p62 and the vitamin D receptor (VDR) was investigated by coimmunoprecipitation (Co‐IP) assays.

Results

p62 was significantly upregulated in CRC, and a high p62 level was an independent risk factor for a poor prognosis in CRC patients. p62 promoted CRC migration and invasion by inhibiting apoptosis and promoting cell proliferation in vitro, and p62 aggravated tumour growth and metastasis in vivo. Co‐IP assays indicated that p62 interacts with the VDR and may target the NRF2‐NQO1 axis.

Conclusions

Our study suggested that p62 functions as an oncogene in CRC through inhibiting apoptosis and promoting cell proliferation by interacting with the VDR.

Publication and source details

Original title: p62 functions as an oncogene in colorectal cancer through inhibiting apoptosis and promoting cell proliferation by interacting with the vitamin D receptor

Jing Zhang; Suzhen Yang; Bing Xu; Ting Wang; Ying Zheng; Fei Liu; Fenggang Ren; Jiong Jiang; Haitao Shi; Baicang Zou; Xiaolan Lu; Shemin Lu; Lei Dong

Cell Proliferation · 2019

* Correspondence
Shemin Lu, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi’an, Shaanxi Province, China.
Email: lushemin@xjtu.edu.cn
and
Lei Dong, Department of Digestive Disease and Gastrointestinal Motility Research Room, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi Province, China.
Email: dong556@126.com
© 2019 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Central government guide the development of local science and technology special funds2016ZY-HM-01National Natural Science Foundation of China 10.13039/50110000180981801310Key research and development program of shanxi province2017SF-1002018ZDXMSF-055Shanxi provincial science & technology plan project2016KTZDSF02-02

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T03:56:21.755570+00:00

DOI: 10.1111/cpr.12585 · PMC6536406